Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs SORAfenib |
Security Level |
 |
Mechanism |
SORAfenib: CYP3A4 Inducers (Strong) may decrease the serum concentration of SORAfenib. |
Management |
Consider therapy modification |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs SORAfenib
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs SORAfenib Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Other Interactions of SORAfenib
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.